Meeting
2023 ASCO Annual Meeting
Chemotherapeutic sensitivity in colorectal cancer expressing low RNA of wild type homologous recombination genes.
Authors
Daniel Walden
Mayo Clinic Arizona, Phoenix, AZ
Daniel Walden , Sachin Deshmukh , Felipe Batalini , Binbin Zheng-Lin , Sharon Wu , Joanne Xiu , Bennett Adam Caughey , John H Strickler , Wolfgang Michael Korn , Emil Lou , Daniel H. Ahn , Christina Wu , Sanjay Goel , Anthony F. Shields , Tanios S. Bekaii-Saab
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3531)
DOI
10.1200/JCO.2023.41.16_suppl.3531
Abstract #
3531
Poster Bd #
231
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
First Author: Jessica A Lavery
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh